Skip to content

Illinois · Public charity

Foundation for Angelman Syndrome Therapeutics

Angelman syndrome (as) is a neurodevelopmental disorder characterized by global development delays and severe speech impairment. A few individuals with as develop functional speech, but most communicate through a mixture of gestures, eye gaze, adapted sign language and augumentative communication devices. Individuals with as have…

$4.1M
Granted FY2019
7
Grants FY2019
6
Organizations funded FY2019
0%
First-time grantees FY2019
Read the full brief

Read this first · the figures below need context

77% of Foundation for Angelman Syndrome Therapeutics’s FY2024 grant dollars went to Trustees Of The University Of Pennsylvania, not to grantees.

Its money now reaches organizations through that sponsor, which does not report who recommended each grant. FY2024 names 7 organizations directly, so a portfolio cannot be read from it. Everything below is therefore FY2019, the last year Foundation for Angelman Syndrome Therapeutics named its own grantees at scale: 6 organizations, $4M. It is dated, not current.

Organizations named directly on the return

6
’17
6
’18
6
’19
4
’20
5
’21
2
’22
9
’23
7
’24

Amber years are those where most dollars went to a sponsor.

Median grant, FY2019
$163,700
Largest grant, FY2019
$1,696,897
Organizations funded a year
6 to 6
FY2017 to FY2019
States reached, FY2019
6
Total assets, FY2019
$45M

How open it is to new grantees

In FY2019, 0% of the organizations Foundation for Angelman Syndrome Therapeutics funded were first-time grantees, receiving 0% of its grant dollars.

New vs renewed · share of each year

In FY2019, 100% of grant dollars renewed an existing relationship; $0 went to new ones.

50%100%’18’19
RenewedFirst-time

Where new relationships form · theme of each grantee’s first grant

’18’19
EducationHealth
How this is measured
First-time means a grantee’s first year in the filing window; renewed means funded in an earlier year too. The renewed share climbs naturally as a portfolio matures, so the signal is a year that bucks it (a wave of new grantees). The earliest year is left-censored: relationships that predate the data read as new. Theme is the grantee’s IRS cause.
The numbers by year
Fiscal yearOrganizations fundedTo those organizationsFirst-time grantees
FY20196$3.2M0%
FY20186$2.3M33%
FY20176$3.7Mn/a
100% classified

What it funded, over time

Every grant placed by its stated purpose and the recipient’s mission, by year, FY2017 to 2024.

Health$20MEducation$8.2MAnimals$2.1MYouth Development$449kScience & Tech$152k

Where its grants go

Grant dollars by states, across the years we hold.

Which US states its grants reach

IL
NY
MA
PA
CT
RI
CA
CO
TN
NC
DC
TX
FL

Top grantees

Largest recipients by total granted, FY2017 to FY2024, and the share of each one’s budget the grants supplied at peak.

GranteeTotal grantedYearsShare of their budget
University of California Davis$4,054,0107n/a
Texas A&M Agrilife Research$3,715,6076n/a
University of South Florida$2,318,9943n/a
Rush University Medical Center$1,608,10020%
Children's Hospital Corporation$949,96430%
Duke University$845,81360%
Nc State University$759,9483n/a
North Carolina State University$448,9822n/a
Vanderbilt University Medical Center$397,04010%
Children's Research Institute$387,44620%
Show all 15 grantees
All grantees of Foundation for Angelman Syndrome Therapeutics by total granted
GranteeTotal grantedYearsShare of their budget
University of California Davis$4,054,0107n/a
Texas A&M Agrilife Research$3,715,6076n/a
University of South Florida$2,318,9943n/a
Rush University Medical Center$1,608,10020%
Children's Hospital Corporation$949,96430%
Duke University$845,81360%
Nc State University$759,9483n/a
North Carolina State University$448,9822n/a
Vanderbilt University Medical Center$397,04010%
Children's Research Institute$387,44620%
Baylor College of Medicine$386,43030%
University of Colorado School of Medicine$383,1631n/a
Keck Graduate Institute of Applied Life Sciences$375,00021%
University of California San Francisco$304,4132n/a
New York University$239,72520%

Where it is load-bearing

Each grantee by its size and the share of its budget Foundation for Angelman Syndrome Therapeutics supplied at peak.

25%50%75%100%$100Mgrantee revenue →↑ funder's share of their budgetRush University Medical Center: $1,608,100 over 2y, 0.1% of budgetChildren's Hospital Corporation: $949,964 over 3y, 0.0% of budgetDuke University: $845,813 over 6y, 0.0% of budgetVanderbilt University Medical Center: $397,040 over 1y, 0.0% of budgetChildren's Research Institute: $387,446 over 2y, 0.3% of budgetBaylor College of Medicine: $386,430 over 3y, 0.0% of budgetKeck Graduate Institute of Applied Life Sciences: $375,000 over 2y, 0.6% of budgetNew York University: $239,725 over 2y, 0.0% of budget

Tap a dot to name the grantee.

How this is measured
Share of budget is the funder’s grant in a year over the grantee’s total revenue that year, at its highest across the years we hold; revenue is from all sources. Only grantees confirmed against their own filings, whose grants do not exceed their revenue, are plotted: the largest 8.

Compare Foundation for Angelman Syndrome Therapeutics with peer funders

Warm introductions · Powered by PlinthPlus

How do I get to Foundation for Angelman Syndrome Therapeutics?

Find your warmest path to Foundation for Angelman Syndrome Therapeutics through trustees and officers whose names appear on both boards. Search for your organization and Plinth traces the shortest route it can evidence.

Each link is a name appearing on two organizations’ public IRS 990 filings, matched on that name and, where the filings support it, on location. A same-state match has geographic support, which is a second matching feature rather than confirmation that the two are one person; a cross-state one is the likeliest to be two people who share a name. Every hop shows its tier, low-confidence and distant paths are held back rather than guessed, and it is worth confirming the person before you use the introduction.

About Foundation for Angelman Syndrome Therapeutics

How much does Foundation for Angelman Syndrome Therapeutics give?
Foundation for Angelman Syndrome Therapeutics reported 7 grants totaling $4,080,080 in its FY2019 IRS filing. It funded between 6 and 6 organizations a year over FY2017 to FY2019.
What does Foundation for Angelman Syndrome Therapeutics fund?
By grant dollars over FY2017 to FY2024, its largest causes are Health (65%), Education (26%), Animals (7%).
Who are Foundation for Angelman Syndrome Therapeutics's largest grantees?
By total granted over FY2017 to FY2024: University of California Davis ($4.1M), Texas A&M Agrilife Research ($3.7M), University of South Florida ($2.3M).
Does Foundation for Angelman Syndrome Therapeutics fund new organizations?
In FY2019, 0% of the organizations it funded were first-time grantees.
Where is Foundation for Angelman Syndrome Therapeutics based?
Foundation for Angelman Syndrome Therapeutics is based in IL.

On method. Every financial figure here is read from IRS e-file XML, the funder’s own 990/990-PF, and from the multi-year returns of the 18 grantees we resolved, each linked to its source. Grantee outcomes are each organization’s own program-service reporting (Form 990, Part III), read as association with funding, never as caused by it. Low-confidence name matches are suppressed rather than guessed. How we build these →

How this is measured
Each figure carries one of six labels. Filed is what the funder reported on its return. Official is another government record about an organization, such as a federal award or a charity register, joined by name where no shared identifier exists. Resolved is an identity we worked out where the filing named a recipient without an EIN, kept only above a measured confidence threshold. Computed is arithmetic over those, like themes, portfolio clusters and co-funder strength. Context is a statistic about a place rather than about an organization, which is what the need overlay is: it describes the area a grantee’s address sits in, not where its work lands. Inferred is drawn by a model from text, like the partnerships read out of public news and organization websites. Each is labeled where it appears.

Generated from the IRS Form 990 e-file return for fiscal year 2019, released 2019. Filings run roughly 12 to 24 months behind; figures are dated accordingly.

Source object · view filing

Play a game based on Foundation for Angelman Syndrome Therapeutics’ filings →

More from the funding graph